Pfizer, Subsidiaries Agree to Pay $345M in EpiPen Settlement


Visor into subsidiaries have agreed to pay three hundred forty five million dollars under a proposed settlement to resolve lawsuits over EpiPen price hikes the litigation goes back five years when lawsuits were filed alleging anti competitive conduct Abby pens auto injectable devices that are used for emergency treatment of a life threatening allergic reaction in two thousand seven and Abby pen package cost about one hundred dollars today it costs more than six hundred fifty dollars without pharmacy coupons or discounts a Pfizer spokesperson denied any wrongdoing and email to Casey you are radio adding this turns the focus on breakthroughs that change patients lives I'm a Donahue

Coming up next